My Ultimate Sign-in System Made Me Invincible Chapter 469 The Old Guards

The exclusive dining chamber in the exclusive club was booked anonymously using a member's name hidden from all public listings, within a structure whose ownership was intentionally shrouded in mystery, for a gathering that produced no records and left no traces behind.

Twelve gentlemen gathered around a table that had witnessed countless such discussions over more than a hundred years. Ancient riches. The sort of fortune that evaded Forbes rankings by being cleverly spread across trusts, foundations, and business entities crafted to dodge any spotlight.

They embodied banking legacies, industrial empires, raw material kingdoms, and investment entities that swayed entire markets without ever revealing their hand. Certain lineages had wielded power during the dismantling of Standard Oil. Others had steered through the birth of the Federal Reserve. Every one of them knew that true authority worked in the shadows, and the subtlest sway was the most potent kind—unseen by all.

The most junior figure among them was sixty-three years old. The senior-most had just hit ninety-two and showed up to each session with the piercing acuity that had forged his clan's status across four generations.

They assembled just eighteen hours after the Medical Nanites reveal, scrapping schedules spanning three continents to appear in person. Virtual calls suited routine dealings. This demanded shared space.

The individual who summoned the assembly addressed them first. His lineage dominated key roles in drug distribution, medical equipment production, and health funding. The nanites reveal had wiped out roughly $40 billion from holdings his family influenced directly or otherwise.

"Let's get absolutely precise on what confronts us," he declared, his tone laced with the measured clarity honed over decades of word selection. "This isn't merely a rival stepping into our domains. This is the obliteration of arenas we've dominated for ages. The difference is crucial."

One investment overseer leaned in. "Our experts have run projections since the news broke. Even with cautious uptake rates, we're facing a total overhaul of health sector finances in under ten years. Drugs, coverage, clinics, gear—the whole pipeline turns redundant or severely scaled back."

"And that's just healthcare," another voice chimed in. "Lucid Studio endangers media creation on the same massive level. We're seeing vast trillion-dollar sectors hit with do-or-die upheavals all at once."

The financier whose kin helped shape the current drug patent framework replied with caution. "The core issue before us is if we can steer this, adjust to it, or merely endure it. I've dedicated the last day connecting with allies in oversight offices, legislative halls, and global organizations. The shared view is alarming. Nobody holds sway. Oversight power stops at extraterrestrial sites. Financial squeezes fail against those not chasing funds or alliances. Lobbying crumbles when masses champion the innovation."

"And that's just healthcare," someone else added. "Lucid Studio threatens entertainment production at similar scale. We're watching multiple trillion-dollar industries face existential disruption simultaneously."

The banker whose family had helped establish the modern pharmaceutical patent system spoke carefully. "The question we need to answer is whether this is something we can influence, adapt to, or simply must accept. I've spent the past day reaching out to contacts in regulatory agencies, congressional offices, and international bodies. The consensus is troubling. No one has leverage. Regulatory authority doesn't extend to off-world facilities. Economic pressure doesn't work when they're not seeking capital or partnerships. Political pressure fails when public opinion overwhelmingly supports the technology."

"How about their banking ally?" a voice inquired. "Whitlock from JP Morgan. He talks straight with them."

"He's proven... reluctant," the financier noted with finesse. "Not aggressive. Yet he's emphasized that his ties to Nova Technologies aren't something he'd jeopardize for us. He extended the same polite alert to us as to the authorities—early word of an impending shift. That's all."

The chamber took in that revelation without a word.

The tycoon whose wealth stemmed from mining and production ventures voiced his thoughts next. His dynasty had endured tech upheavals in the past—from coal's decline to oil's surge, factory mechanization, the advent of digital tools that supplanted tangible outputs. Yet this seemed utterly distinct.

"We've survived by snapping up fresh innovations, weaving them into our empires, and holding ground via mastery of vital networks," he stated. "That approach demands the tech be buyable. Nova Technologies refuses sales. They shun funding. They withhold IP licenses. There's no purchase option, no absorption route, no dominance channel."

"Did we float buyout bids?" another queried.

"Naturally. Right after Lucid's debut, we dispatched go-betweens with acquisition pitches. Unlimited funds on offer. Replies? None. We've retried since, yielding the same void. They're plainly uninterested in takeover at any cost."

"What of their logistics chain? Can we pinpoint weaknesses, gain footing via vendors or fabricators?"

"We've probed. Their chain is either totally veiled or defies standard molds. Top intel points to production in unknown spots via baffling methods. The extraterrestrial site mention in the Medical Nanites reveal backs this hunch."

One of the less senior attendees—at sixty-three, that is—piped up. "Maybe we're tackling this backward. Rather than dominating Nova Technologies, let's angle to profit from the chaos they're unleashing. Spot the side benefits, supporting offerings, the base builds arising from their tech rollout."

The patriarch, silent till now, let out a faint noise akin to a chuckle. All eyes swung his way.

"That's apt for a risk-taker or chance-seizer," he remarked, his voice frail yet distinct. "Not for clans whose strength rests on ruling core mechanisms. We don't join trades. We forge them. That's the secret to lasting riches over eras. Nova Technologies isn't merely shaking trades. It's reshaping the frameworks we've embedded ourselves in across generations."

He halted, and the gathering held its breath.

"The present health framework was erected on purpose. Not instantly, not by one force, but via layered choices from folks in spots like ours. Patent rules shielding drug gains. Oversight setups erecting entry walls. Coverage models draining worth from certainties. No plot here. Just authority clustering around limited goods. We carved profits from shortages—in cures, therapies, care entry."

"Nova Technologies erases the shortages. When rarity vanishes, the whole framework for siphoning gains via shortage management turns pointless. That's no mere shift we tweak through asset juggling. That's a rewrite of the game's core rules."

The chamber hung in utter quiet.

"So what's our move?" a participant pressed.

The elder weighed it. "When up against unstoppable tides, we face facts. Safeguard the salvageable. Shift clear of doomed holdings. Train the heirs to flourish in the arising order, not cling to a fading one."

"That's surrender," the drug successor snapped, tone sharpened. "We're yielding just like that?"

"I'm urging we skip squandering effort on lost causes. The Medical Nanites are here. Trials will prove their power. Crowd demand will compel rulers to greenlight launches. We pick: exhaust ourselves delaying doom and alienating potential allies, or pivot fast and stay pertinent in the fresh regime."

"Could we leverage our press assets to mold views?" one proposed. "Stir fears on reliability—"

"No." The banker's retort cut sharp and absolute. "I've eyed the reports you know. Any public strike at Nova Technologies will rebound disastrously. They're handing fixes for cancer, Alzheimer's, immobility. Standing against that paints us as outright foes. The masses would dismantle us, and they'd be justified."

The private funds director summoned a file on his device. "My crew's simulated paths. The routes keeping max riches and clout involve aiding Nova Technologies' push, providing side services, and redirecting assets to those boosted by, not battling, their inventions. The paths to total ruin stem from direct clashes or sabotage attempts."

"So we hand them victory?"

"Victory's theirs already," the elder murmured softly. "They claimed it by unveiling irreplaceable tech from untouchable bases with unbreakable crowd backing. Now it's about enduring their imposed shift or gripping the past till it sinks us too."

Another heavy hush blanketed the space.

The convener spoke once more. "I suggest we adopt an official stance. No public resistance to Nova Technologies. No efforts to sabotage their tech or spread. Seek collab chances where possible. Move holdings from endangered spots to enduring or gaining ones in the new terrain. Ready the youth for a realm where our old sway sources dwindle sharply."

He scanned the group. "This isn't my preferred end. But it's our truth. Aye votes?"

Eleven arms lifted. Some swift, others hesitant, yet all complied in time.

"Passed," the convener announced.

The session stretched another hour, turning to tactics and operations. Assets to offload and schedules. Alliances to chase. Heirs needing landscape updates. Ways to sustain clan treasures and sway in a globe where Nova Technologies upended capital, tech, and authority bonds.

Yet the key verdict stood firm. They wouldn't battle Nova Technologies. They'd conform to the world the firm forged, guard what endured, and trust teamwork might retain some sway in the unfolding order.

It stung for lords whose bloodlines had hoarded the might that typically warped worlds to fit. But pragmatism let them spot an unyielding, unbribable, unbreakable foe.

As the session wrapped, attendees scattered to discreet rides and flights, heading to global abodes and desks. None rehashed the talk. Such events unfolded, calls were set, then life resumed sans mention.

Still, in hushed advisor chats, impacts would spread.

The veteran elite chose their path. No stand against Nova Technologies' forged tomorrow. Just efforts to carve a niche safeguarding slivers of century-built legacies.

It was reluctant shift, driven by must, not zeal. Adaptation all the same.

And across global suites and elite dens, like minds held mirror talks, drawing like verdicts via akin logic.

Their unchallenged rule waned. Now, how much endurance in the handover, and if their edifice lingered reduced or vanished clean?

No sure reply existed. But all saw open war on Nova Technologies sealed the direst fate.